• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Goodyear Tire & Rubber Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket

    11/1/22 6:33:47 AM ET
    $ACOR
    $ARBK
    $BACK
    $BZ
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $ACOR alert in real time by email

    Gainers

    • Quotient Limited (NASDAQ:QTNT) rose 60.7% to $0.1295 in pre-market trading. Quotient shares dipped 37% on Monday after the company announced a 1-for-40 reverse stock split.
    • PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) shares rose 25.3% to $0.1296 in pre-market trading. PhaseBio Pharmaceuticals said on October 25, 2022 that it received notice from the Nasdaq stating it has determined that company’s securities will be delisted from Nasdaq.
    • Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) rose 21.8% to $3.46 in pre-market trading after dropping over 10% on Monday.
    • IMAC Holdings, Inc. (NASDAQ:BACK) rose 12.3% to $0.43 in pre-market trading after declining over 6% on Monday.
    • RLX Technology Inc. (NYSE:RLX) rose 12% to $1.40 in pre-market trading after declining over 7% on Monday.
    • GDS Holdings Limited (NASDAQ:GDS) shares rose 11.9% to $9.66 in pre-market trading after dipping more than 10% on Monday.
    • H World Group Limited (NASDAQ:HTHT) shares rose 9.9% to $29.75 in pre-market trading.
    • Kanzhun Limited (NASDAQ:BZ) rose 9.8% to $12.00 in pre-market trading.
    • Carvana Co. (NYSE:CVNA) rose 9.3% to $14.79 in pre-market trading after dropping more than 6% on Monday.
    • Gaotu Techedu Inc. (NYSE:GOTU) rose 8.9% to $0.72 in pre-market trading.
    • iQIYI, Inc. (NASDAQ:IQ) rose 8.9% to $2.20 in pre-market trading.
    • Xunlei Limited (NASDAQ:XNET) rose 8.8% to $1.08 in pre-market trading after declining 7% on Monday.
    • Trip.com Group Limited (NASDAQ:TCOM) shares rose 8.8% to $24.62 in pre-market trading.
    • Hologic, Inc. (NASDAQ:HOLX) rose 4.9% to $71.12 in pre-market trading after the company reported better-than-expected Q3 EPS and sales results.


    Don’t forget to check out our premarket coverage here .


    Losers

    • Varonis Systems, Inc. (NASDAQ:VRNS) shares fell 28% to $19.27 in pre-market trading after the company reported worse-than-expected Q3 results.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares fell 15.1% to $0.9090 in pre-market trading after jumping over 63% on Monday.
    • Argo Blockchain plc (NASDAQ:ARBK) fell 9.9% to $1.00 in pre-market trading. Argo Blockchain shares dipped around 44% on Monday after the company announced it believes its previously announced non-binding LOI with a strategic investor to raise $27 million via a subscription for ordinary shares will no longer be conssumated.
    • Flora Growth Corp. (NASDAQ:FLGC) fell 9.7% to $0.56 in pre-market trading. Flora Growth recently signed a definitive agreement to acquire Franchise Global Health Inc (FGH), a multi-national operator in the medical cannabis and pharmaceutical industry.
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) shares fell 9.5% to $0.2032 in pre-market trading after dropping 8% on Monday.
    • The Goodyear Tire & Rubber Company (NASDAQ:GT) fell 9% to $11.56 in pre-market trading after the company reported worse-than-expected Q3 earnings.
    • Liquid Media Group Ltd. (NASDAQ:YVR) shares fell 7.8% to $0.2711 in pre-market trading. Liquid Media, last month, announced Q3 sales were up year over year.
    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) fell 6.7% to $1.80 in pre-market trading. Sonnet BioTherapeutics shares jumped 66% on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product candidates.
    • 1847 Holdings LLC (NASDAQ:EFSH) fell 5.7% to $2.48 in pre-market trading. 1847 Holdings shares jumped around 40% on Monday after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its existing portfolio.
    • Stryker Corporation (NYSE:SYK) fell 5.4% to $216.80 in pre-market trading after the company reported worse-than-expected Q3 results and issued 2022 guidance below estimates.
    Get the next $ACOR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACOR
    $ARBK
    $BACK
    $BZ

    CompanyDatePrice TargetRatingAnalyst
    Varonis Systems Inc.
    $VRNS
    3/23/2026Outperform → Mkt Perform
    William Blair
    H World Group Limited
    $HTHT
    3/9/2026$62.40Neutral → Buy
    UBS
    Varonis Systems Inc.
    $VRNS
    3/3/2026$28.00Overweight
    Wells Fargo
    Stryker Corporation
    $SYK
    2/20/2026Outperform
    William Blair
    Varonis Systems Inc.
    $VRNS
    2/5/2026$30.00Neutral → Buy
    DA Davidson
    Stryker Corporation
    $SYK
    1/27/2026$387.00Hold
    TD Cowen
    Varonis Systems Inc.
    $VRNS
    1/26/2026$41.00Overweight → Equal-Weight
    Morgan Stanley
    Hologic Inc.
    $HOLX
    1/12/2026Buy → Hold
    Argus
    More analyst ratings

    $ACOR
    $ARBK
    $BACK
    $BZ
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 29, 2024 - FDA Roundup: October 29, 2024

    For Immediate Release: October 29, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA responded to objections on the agency’s final rule that removed the authorized food contact uses of most phthalates because industry abandoned these uses. The FDA evaluated the objections and concluded that they did not provide a basis for mod

    10/29/24 3:30:19 PM ET
    $HOLX
    Medical Electronics
    Health Care

    February 2, 2024 - FDA Roundup: February 2, 2024

    For Immediate Release: February 02, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a safety communication to warn consumers, health care providers, and health care facilities not to use certain Cardinal Health Monoject luer-lock and enteral syringes. Dimensional changes made to the syringes, when used with syringe pump

    2/2/24 3:58:21 PM ET
    $HOLX
    Medical Electronics
    Health Care

    $ACOR
    $ARBK
    $BACK
    $BZ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, President, Chairman Faitelson Yakov bought $598,907 worth of shares (26,725 units at $22.41), gifted 87,000 shares, received a gift of 78,928 shares and was granted 315,674 shares, increasing direct ownership by 14% to 2,098,387 units (SEC Form 4)

    4 - VARONIS SYSTEMS INC (0001361113) (Issuer)

    2/10/26 7:31:52 PM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    EVP Engineering & CTO Bass David was granted 169,095 shares and bought $69,941 worth of shares (2,980 units at $23.47), increasing direct ownership by 20% to 1,042,924 units (SEC Form 4)

    4 - VARONIS SYSTEMS INC (0001361113) (Issuer)

    2/10/26 7:27:11 PM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    Director Gavin John J Jr bought $112,700 worth of shares (5,000 units at $22.54), increasing direct ownership by 2% to 273,666 units (SEC Form 4)

    4 - VARONIS SYSTEMS INC (0001361113) (Issuer)

    2/10/26 7:24:17 PM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    $ACOR
    $ARBK
    $BACK
    $BZ
    SEC Filings

    View All

    SEC Form 6-K filed by KANZHUN LIMITED

    6-K - Kanzhun Ltd (0001842827) (Filer)

    4/2/26 7:07:52 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    SEC Form 6-K filed by KANZHUN LIMITED

    6-K - Kanzhun Ltd (0001842827) (Filer)

    4/1/26 7:28:25 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    SEC Form 15-12G filed by IMAC Holdings Inc.

    15-12G - IMAC Holdings, Inc. (0001729944) (Filer)

    3/31/26 4:44:14 PM ET
    $BACK
    Medical Specialities
    Health Care

    $ACOR
    $ARBK
    $BACK
    $BZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Varonis Systems downgraded by William Blair

    William Blair downgraded Varonis Systems from Outperform to Mkt Perform

    3/23/26 8:28:18 AM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    H World Group upgraded by UBS with a new price target

    UBS upgraded H World Group from Neutral to Buy and set a new price target of $62.40

    3/9/26 8:43:21 AM ET
    $HTHT
    Hotels/Resorts
    Consumer Discretionary

    Wells Fargo initiated coverage on Varonis Systems with a new price target

    Wells Fargo initiated coverage of Varonis Systems with a rating of Overweight and set a new price target of $28.00

    3/3/26 8:31:55 AM ET
    $VRNS
    Computer Software: Prepackaged Software
    Technology

    $ACOR
    $ARBK
    $BACK
    $BZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carvana to Report First Quarter 2026 Results and Host Quarterly Conference Call on April 29

    Carvana (NYSE:CVNA), the industry pioneer for buying and selling cars online, today announced it will report its first quarter 2026 financial results for the period ended March 31, 2026, after the market closes on Wednesday, April 29, 2026. On that day, management will hold a conference call and webcast at 5:30 p.m. ET (2:30 p.m. PT) to review and discuss the company's business and results. What:   Carvana First Quarter 2026 Financial Results Conference Call When:   Wednesday, April 29, 2026 Time:   5:30 p.m. ET (2:30 p.m. PT) Live Call:   (833) 255-2830 or (412) 902-6715 An archived webcast of the conference call will be accessible

    4/1/26 9:00:00 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Stryker to announce financial results for its first quarter of fiscal year 2026

    Portage, Michigan, April 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its first quarter of fiscal year 2026 on Thursday, April 30, 2026.  A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company's first quarter that ended March 31, 2026. Stryker will host a webcast at 4:30 p.m. ET on Thursday, April 30, 2026, to discuss its first quarter 2026 results.  The webcast can be accessed at Stryker - Events & Presentations.  An archive of the webcast will also be available on the company's website two hours afte

    4/1/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker names Nick Mead Vice President, Investor Relations

    Portage, Michigan, March 31, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today Nick Mead has been appointed Vice President, Investor Relations, effective May 1, 2026. Mead has nearly 20 years of experience at Stryker, with leadership roles spanning multiple divisions and business units across the company. Most recently, he served as Vice President, Finance for Stryker's Medical division, where he partnered closely with senior leaders to support commercial strategy, capital allocation and operational execution. "Nick brings deep institutional knowledge, strong financial expertise and a proven ability to support strategic decision making

    3/31/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $ACOR
    $ARBK
    $BACK
    $BZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Breaux Paul W.

    4 - CARVANA CO. (0001690820) (Issuer)

    4/3/26 4:29:11 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form 4 filed by Taira Thomas

    4 - CARVANA CO. (0001690820) (Issuer)

    4/3/26 4:29:17 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form 4 filed by Keeton Ryan S.

    4 - CARVANA CO. (0001690820) (Issuer)

    4/3/26 4:29:07 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $ACOR
    $ARBK
    $BACK
    $BZ
    Leadership Updates

    Live Leadership Updates

    View All

    GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors

    GE HealthCare (NASDAQ:GEHC) announced today the appointment of Kevin A. Lobo, Chair and Chief Executive Officer of Stryker Corporation (NYSE:SYK), to its Board of Directors effective March 13. Mr. Lobo brings more than 25 years of medical technology, operational, and financial leadership experience. His clinical expertise and track record of driving innovation and scaling global businesses make him well qualified to contribute to GE HealthCare's strategic priorities. "Kevin is a seasoned healthcare executive with a deep understanding of the medical technology landscape. His knowledge and insight will further strengthen our Board as we continue to build a more personalized, connected and s

    3/17/26 9:00:00 AM ET
    $GEHC
    $SYK
    Medical Electronics
    Health Care
    Medical/Dental Instruments

    Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting

    Evolving technologies and offerings reinforce commitment to shaping the future of orthopaedic care PORTAGE, Mich., March 3, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases its commitment to innovation across orthopaedic specialties with the introduction of the newest additions to the Triathlon® Total Knee System, the expanded Mako SmartRobotics™ portfolio and continued evolution of the power tool portfolio at the American Academy of Orthopaedic Surgeons' (AAOS) 2026 Annual Meeting in New Orleans. Triathlon Gold: Building on the legacy

    3/3/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    $ACOR
    $ARBK
    $BACK
    $BZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $ACOR
    $ARBK
    $BACK
    $BZ
    Financials

    Live finance-specific insights

    View All

    Carvana to Report First Quarter 2026 Results and Host Quarterly Conference Call on April 29

    Carvana (NYSE:CVNA), the industry pioneer for buying and selling cars online, today announced it will report its first quarter 2026 financial results for the period ended March 31, 2026, after the market closes on Wednesday, April 29, 2026. On that day, management will hold a conference call and webcast at 5:30 p.m. ET (2:30 p.m. PT) to review and discuss the company's business and results. What:   Carvana First Quarter 2026 Financial Results Conference Call When:   Wednesday, April 29, 2026 Time:   5:30 p.m. ET (2:30 p.m. PT) Live Call:   (833) 255-2830 or (412) 902-6715 An archived webcast of the conference call will be accessible

    4/1/26 9:00:00 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    BOSS Zhipin Continues Share Repurchase Program; Cumulative Repurchases Reach Nearly RMB450 Million in FY26

    BEIJING, March 25, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HK: 2076)) today announced the continued execution of its share repurchase program, utilizing around RMB34.4 million to repurchase 748,552 ordinary shares on March 24. Year-to-date in 2026, the Company has deployed nearly RMB450 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns. On March 18, 2026, the Company's board of directors (the "Board") approved amendments to the existing share repurchase program, increasing the total authorization under the program to repurchase up to US$400 million of the Company's shares (including

    3/25/26 6:30:00 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    BOSS Zhipin Continues Share Repurchase Program, Reinforcing Commitment to Shareholder Returns

    BEIJING, March 23, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HK: 2076)) today announced the continued execution of its share repurchase program, utilizing around RMB34.5 million to repurchase 733,918 ordinary shares on March 20. Year-to-date in 2026, the Company has deployed around RMB380 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns. On March 18, 2026, the Company's board of directors (the "Board") approved amendments to the existing share repurchase program, increasing the total authorization under the program to repurchase up to US$400 million of the Company's shares (including

    3/23/26 4:30:00 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology